Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial laser prostatectomy

A P Perlmutter1, R Muschter

  • 1Department of Urology, New York Hospital, New York, USA.

Mayo Clinic Proceedings
|September 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].

Der Urologe. Ausg. A·2015
Same author

[S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Der Urologe. Ausg. A·2015
Same author

[Transurethral resection of the prostate and current modifications (bipolar, electrovaporization)].

Der Urologe. Ausg. A·2013
Same author

[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].

Der Urologe. Ausg. A·2013
Same author

The use of mannitol in partial and live donor nephrectomy: an international survey.

World journal of urology·2012
Same author

[Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].

Der Urologe. Ausg. A·2009

Interstitial laser coagulation offers a safe alternative for benign prostatic hyperplasia, effectively reducing symptoms and prostate volume with minimal side effects. This minimally invasive procedure is suitable even for high-risk patients.

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Laser Therapeutics

Background:

  • Transurethral resection of the prostate (TURP) is the standard treatment for benign prostatic hyperplasia (BPH).
  • Alternatives to TURP are sought to minimize hospitalization and perioperative morbidity.
  • Laser prostatectomy techniques have been developed as alternatives.

Purpose of the Study:

  • To evaluate interstitial laser coagulation (ILC) as an alternative treatment for BPH.
  • To assess the safety and efficacy of ILC in relieving bladder outlet obstruction.

Main Methods:

  • Interstitial laser coagulation involves inserting laser-diffusing fibers into the prostatic adenoma.
  • The procedure aims to induce coagulation necrosis, leading to prostatic lobe regression.

Related Experiment Videos

  • Application can be via transurethral cystoscopic or perineal approaches.

    • Main Results:

    • ILC effectively decreases symptoms of prostatism and increases urinary flow rate.
    • The procedure leads to a reduction in prostate volume.
    • Potential side effects include temporary catheterization (7-21 days) and occasional retrograde ejaculation (0-11.9%).

    Conclusions:

    • Interstitial laser coagulation is a safe and effective treatment for BPH.
    • It is associated with minimal blood loss and fluid shifts, making it suitable for high-risk patients.
    • No cases of impotence or sustained incontinence have been reported.